Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

300-Patient registry tracks nellix® aneurysm sealer in Real-World use

NCT ID NCT02018744

Knowledge-focused Sponsor: Endologix Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed registry followed 300 patients with abdominal aortic aneurysm who were treated with the Nellix® Endovascular Sealing System across 30 international centers. The goal was to see how well the device performs in everyday medical practice, measuring safety and effectiveness over up to five years. Researchers tracked complications like aneurysm rupture, device migration, and the need for additional procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nellix® Endovascular Sealing System (a device used to seal abdominal aortic aneurysms from inside the blood vessel)
What this could lead to
If the results confirm the device works well in everyday practice, it could support its continued use for treating abdominal aortic aneurysms.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the device is better than other treatments. Results may vary across centers and patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

300 people

The number who actually took part.

Started

Oct 2013

Finished

Jul 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Up to 300 patients diagnosed with AAA who are considered candidates for Endovascular Repair, who meet the study eligibility criteria and sign the Informed consent may be subsequently enrolled in the study

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female at least 18 years old 2. Subject has signed informed consent for data release 3. Subjects with AAA and eligible for endovascular repair Exclusion Criteria: 1. Currently participating in another study where primary endpoint has not been reached yet 2. Known allergy to any of the device components 3. Pregnant (females of childbearing potential only)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal aortic aneurysm are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Safety and performance of the nellix endovascular sealing system

Contacts and locations

Locations

  • Academisch Medisch Centrum Amsterdam, Department of Surgery

    Amsterdam, 1105AZ, Netherlands

  • Addenbrooke's Hospital, Dept of Vascular Surgery

    Cambridge, CB20QQ, United Kingdom

  • Alfried Krupp Krankenhaus Ruttenscheid, Vascular Centre

    Essen, 45131, Germany

  • Auckland City Hospital Interventional Radiology

    Auckland, 1023, New Zealand

  • Erasmus Medical Centre, Dept of Vascular Surgery

    Rotterdam, 3015 CE, Netherlands

  • Hopital Kirchberg, Dept of Cardio-Vascular

    Luxembourg-Kirchberg, L-2540, Luxembourg

  • Hospital Hamar

    Hamar, 2326, Norway

  • Karolinska University Hospital

    Stockholm, SE-171, Sweden

  • Klinikum Augsburg Klinik für Gefäßchirurgie

    Augsburg, 86156, Germany

  • Klinikum Stuttgart Katharinenen Hospital

    Stuttgart, 70174, Germany

  • Klinikum Sud Nuernberg, Dept of Vascular Surgery

    Nuremberg, 90471, Germany

  • Orebro University Hospital, Department of General Surgery

    Örebro, Sweden

  • Pauls Stadins Clinical University Hospital Riga

    Riga, LV-1002, Latvia

  • Rijnstate Ziekenhuis, Vasculaire Centrum

    Arnhem, 6800 TA, Netherlands

  • St Antonius Ziekenhuis, Dept of Vascular Surgery

    Nieuwegein, 3435 CM, Netherlands

  • St Elisabeth Ziekenhuis, Dept of Vascular Surgery

    Tilburg, 5022 GC, Netherlands

  • St. George's Vascular Institute

    London, SW170QT, United Kingdom

  • Universitätsklinikum Düsseldorf Klinik für Gefäß- und Endovaskularchirurgie

    Düsseldorf, 40225, Germany

  • Universitätsklinikum Heidelberg Klinik für Gefäßchirurgie Im Neuenheimer Feld

    Heidelberg, 69120, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.